Search
Now showing items 1221-1230 of 1253
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Ng, Yuen Lam Dora et al. (2022)
Wissenschaftlicher Artikel
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Duncavage, Eric J. et al. (2022)
Wissenschaftlicher Artikel
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1
Tausch, Eugen et al. (2020)
Wissenschaftlicher Artikel
getITD for FLT3-ITD-based MRD monitoring in AML
Blaette, Tamara J. et al. (2019)
Wissenschaftlicher Artikel
Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders
Hofmann, Susanne et al. (2019)
Wissenschaftlicher Artikel
Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways
Groeschel, Stefan et al. (2015)
Wissenschaftlicher Artikel
Midostaurin in FLT3-Mutated Acute Myeloid Leukemia REPLY
Stone, Richard M.; Larson, Richard A.; Döhner, Hartmut (2017)
Wissenschaftlicher Artikel
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
Voso, Maria Teresa et al. (2020)
Wissenschaftlicher Artikel
Defective Drosha Processing contributes to Downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
Allegra, Danilo; Philippen, Angela; Döhner, Hartmut; Stilgenbauer, Stephan; Mertens, Daniel (2011)
Forschungsdaten
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
de Botton, Stephane et al. (2023)
Wissenschaftlicher Artikel